Theriva Biologics Total Risk Alpha
| TOVX Stock | | | USD 0.19 0.0004 0.21% |
Reference data associated with the Total Risk Alpha technical indicator for Theriva Biologics. Coverage may vary across instruments due to feed availability.
Theriva Biologics has current Total Risk Alpha of 0.1974. The total risk alpha measures the performance of an asset by comparing its returns with those of a selected benchmark portfolio.
Total Risk Alpha | = | RFR + (ER[b] - ER[a]) | x | STD[a] / STD[b] |
| = | 0.1974 | |
| ER[a] | = | Expected return on investing in Theriva Biologics |
| ER[b] | = | Expected return on market index or selected benchmark |
| STD[a] | = | Standard Deviation of returns on Theriva Biologics |
| STD[b] | = | Standard Deviation of selected market or benchmark |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
Theriva Biologics Total Risk Alpha Peers Comparison
Theriva Total Risk Alpha Relative To Other Indicators
Theriva Biologics is rated
fourth in total risk alpha among leading competitors. It is currently under evaluation in maximum drawdown among leading competitors reporting about
192.98 of Maximum Drawdown per Total Risk Alpha. At
192.98 , Theriva Biologics's Maximum Drawdown-to-Total Risk Alpha multiple reflects the spread between these metrics
The benchmark portfolio represents the market risk matched to the total risk of the stock ETF or fund.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.